LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 2.49 | 771.67 | 936 | 867 | 1.0787 | 2.1279 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.71 | 771.67 | 959 | 956 | 1.0027 | 1.0178 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 4.71 | 771.67 | 1034 | 956 | 1.0812 | 1.5734 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.94 | 771.67 | 1083 | 1045 | 1.0362 | 1.1695 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 6.94 | 771.67 | 1053 | 1045 | 1.0075 | 1.0346 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 9.16 | 771.67 | 1169 | 1138 | 1.0268 | 1.0965 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 9.16 | 771.67 | 1272 | 1138 | 1.1173 | 1.4370 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 11.56 | 771.67 | 1306 | 1280 | 1.0198 | 1.0544 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 11.56 | 771.67 | 1448 | 1280 | 1.1307 | 1.3661 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 13.78 | 771.67 | 1449 | 1459 | 0.9926 | 0.9840 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 13.78 | 771.67 | 1642 | 1459 | 1.1249 | 1.2729 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.00 | 771.67 | 1599 | 1585 | 1.0085 | 1.0164 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 16.00 | 771.67 | 1842 | 1585 | 1.1618 | 1.3106 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.22 | 771.67 | 1768 | 1741 | 1.0153 | 1.0260 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 18.22 | 771.67 | 2042 | 1741 | 1.1726 | 1.2905 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.44 | 771.67 | 1922 | 1910 | 1.0058 | 1.0089 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 20.44 | 771.67 | 2204 | 1910 | 1.1534 | 1.2305 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.66 | 771.67 | 2142 | 2141 | 1.0002 | 1.0003 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 22.66 | 771.67 | 2394 | 2141 | 1.1179 | 1.1573 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.89 | 771.67 | 2358 | 2397 | 0.9834 | 0.9797 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 24.89 | 771.67 | 2678 | 2397 | 1.1169 | 1.1398 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.11 | 771.67 | 2653 | 2675 | 0.9917 | 0.9908 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 27.11 | 771.67 | 3038 | 2675 | 1.1356 | 1.1470 | MN20160304_L01 | M15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.33 | 771.67 | 2934 | 2939 | 0.9982 | 0.9981 | MN20160304_L01 | L18 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.0033333 | 29.33 | 771.67 | 3359 | 2939 | 1.1428 | 1.1432 | MN20160304_L01 | M15 |